ÂÌñÏׯÞ

ÂÌñÏׯÞ

Menu Close

Nigeria immunises 1.09m people with AstraZeneca COVID-19 Vaccine ─NPHCDA

Dr. Faisal Shuaibu, Executive Director of NPHCDA Taking AstraZeneca Vaccine Shot in Abuja, FCT

*Analysis of the vaccination update contained in Electronic Management of Immunisation Data System indicates Lagos State leads the pack in the vaccination exercise with 203,697 persons

Alexander Davis | ÂÌñÏׯÞ

In continuation of vaccinations of the people against the Coronavirus (COVID-19) pandemic in the country, Nigerian regulators have said the country thus far has administered a total of 1,096,727 first doses of AstraZeneca Vaccine.

The National Primary Health Care Development Agency (NPHCDA), in an update stated the figure represents 54.5 percent of the eligible persons targeted in Nigeria, agency report said.

Analysis of the vaccination update contained in an Electronic Management of Immunisation Data, (EMID) System indicated that Lagos remains ahead in the exercise with 203,697 persons vaccinated.

Trailing Lagos  are Kano, 58,353; Kaduna, 56,694; Ogun, 53,255; the FCT, 49,192; Katsina, 39,441; Bauchi, 36,196; Oyo, 37,878; Ondo, 31,476; Kwara, 31,208; Edo, 29,173; Jigawa, 28,272; Plateau, 28,567; Gombe, 27,285; Niger, 27,215; Rivers, 28,934; Ekiti, 22,977; and Benue, 22,261.

Others are Borno, 21,635; Delta, 21,345; Osun, 21,240; Yobe, 21,071;     Adamawa, 20,054; Imo, 19,362;  Nasarawa, 17,675; Kebbi, 15,939; Zamfara, 15,854; Cross River, 15,281; Akwa Ibom, 12,553; Enugu, 12,144; Sokoto, 11,837;  Anambra, 10,982 and Bayelsa, 10,662, Ebonyi, 8,927; Taraba, 8,928; Abia,  9,363 and Kogi 9,801.

In view of the current global shortfall of COVID-19 Vaccines for immunisation and late commencement of the vaccination in some states of the Federation, the health agency noted that it is expanding the eligibility period between the first and second doses of the vaccine from 12 weeks to 8 to 12 weeks.

According to NPHCDA, the move is in line with the scientific recommendation provided by the World Health Organisation’s (WHO) Strategic Advisory Group of Experts (SAGE) on immunisation that the two doses of the vaccine be given to consumers at 8-12 weeks intervals.

Kindly Share This Story

Kindly share this story